SE8703632L - For fordrojd frigivning anordnad fluoridkomposition - Google Patents

For fordrojd frigivning anordnad fluoridkomposition

Info

Publication number
SE8703632L
SE8703632L SE8703632A SE8703632A SE8703632L SE 8703632 L SE8703632 L SE 8703632L SE 8703632 A SE8703632 A SE 8703632A SE 8703632 A SE8703632 A SE 8703632A SE 8703632 L SE8703632 L SE 8703632L
Authority
SE
Sweden
Prior art keywords
delayed release
fluoride composition
fluoride
release moved
moved
Prior art date
Application number
SE8703632A
Other languages
Unknown language ( )
English (en)
Other versions
SE502686C2 (sv
SE8703632D0 (sv
Inventor
M G Grodberg
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of SE8703632D0 publication Critical patent/SE8703632D0/sv
Publication of SE8703632L publication Critical patent/SE8703632L/sv
Publication of SE502686C2 publication Critical patent/SE502686C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
SE8703632A 1986-09-25 1987-09-21 För fördröjd frigivning anordnad fluoridkomposition SE502686C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/911,608 US4859467A (en) 1986-09-25 1986-09-25 Sustained release fluoride composition

Publications (3)

Publication Number Publication Date
SE8703632D0 SE8703632D0 (sv) 1987-09-21
SE8703632L true SE8703632L (sv) 1988-03-26
SE502686C2 SE502686C2 (sv) 1995-12-11

Family

ID=25430557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703632A SE502686C2 (sv) 1986-09-25 1987-09-21 För fördröjd frigivning anordnad fluoridkomposition

Country Status (21)

Country Link
US (1) US4859467A (sv)
JP (1) JP2594576B2 (sv)
AR (1) AR242497A1 (sv)
AU (1) AU607154B2 (sv)
BE (1) BE1000159A5 (sv)
BR (1) BR8704889A (sv)
CA (1) CA1294551C (sv)
CH (1) CH672071A5 (sv)
DE (1) DE3727616A1 (sv)
DK (1) DK494887A (sv)
FR (1) FR2604360B1 (sv)
GB (1) GB2195245B (sv)
IL (1) IL83652A (sv)
IT (1) IT1211791B (sv)
MX (1) MX164095B (sv)
NL (1) NL8702297A (sv)
NO (1) NO178527C (sv)
NZ (1) NZ221539A (sv)
PH (1) PH25636A (sv)
SE (1) SE502686C2 (sv)
ZA (1) ZA876281B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861590A (en) * 1986-09-25 1989-08-29 Colgate-Palmolive Company Sustained release fluoride and calcium composition
US5776493A (en) * 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
US5039526A (en) * 1990-04-16 1991-08-13 Colgate-Palmolive Company Buccal lozenge for fluoride ion medication
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US5153005A (en) * 1990-12-11 1992-10-06 Colgate-Palmolive Company Composition and method for preventing fluorosis
DE4108239A1 (de) * 1991-03-14 1992-09-17 Merck Patent Gmbh Pellets enthaltend natriummonofluorphosphat
DE4236090C1 (de) * 1992-10-26 1994-01-05 Asta Medica Arzneimittel Pharmazeutische Zubereitung für die Fluoridionen-Versorgung
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US20050002996A1 (en) * 2003-07-02 2005-01-06 Milan Sojka Sustained release compositions and controlled delivery method
JP3818295B2 (ja) 2004-02-27 2006-09-06 オムロンヘルスケア株式会社 血圧計測装置
WO2015069261A1 (en) 2013-11-07 2015-05-14 Halliburton Energy Services, Inc. In-situ generation of acid for use in subterranean formation operations

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2449184A (en) * 1944-03-08 1948-09-14 Ayerst Mckenna & Harrison Oral fluoride-vitamin preparation
US2627493A (en) * 1949-02-05 1953-02-03 Wallace & Tiernan Inc Fluorine chewing gum process
US2967131A (en) * 1954-02-08 1961-01-03 Charles J Nemanick Therapeutic composition
NL254647A (sv) * 1959-08-07
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
US3431339A (en) * 1966-07-20 1969-03-04 Colgate Palmolive Co Dentifrices
SE364636B (sv) * 1968-01-16 1974-03-04 S Ericsson
BE731578A (sv) * 1969-04-16 1969-10-01
GB1408922A (en) * 1972-02-02 1975-10-08 Blendax Werke Schneider Co Process and composition for the remineralisation and prevention of demineralisation of human teeth
DE2456667A1 (de) * 1974-11-30 1976-08-12 Henkel & Cie Gmbh Verfahren zum stabilisieren von calciumhydrogenphosphat-anhydrid gegen die umsetzung mit fluorionen
DE2630326C2 (de) * 1976-07-06 1983-07-21 "Gebro" G. Broschek Kg, Chemisch-Pharmazeutische Fabrik, 6391 Fieberbrunn, Tirol Präparat zur Behandlung der Osteoporose und seine Herstellung
DE2712161C2 (de) * 1977-03-19 1983-01-05 Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz Zahn- und Mundpflegemittel
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4265877A (en) * 1980-02-22 1981-05-05 Tenta Louis T Composition containing sodium fluoride in a chewing gum base
FR2497665A1 (fr) * 1981-01-09 1982-07-16 Francis Haas Capsule molle gastro-resistante de fluorure de sodium a haute dose, et procede d'obtention d'une telle capsule
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe
US4532124A (en) * 1981-08-19 1985-07-30 Development Finance Corporation Of New Zealand Dental rinse
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPS59175435A (ja) * 1983-03-18 1984-10-04 リジスキイ・メデイツインスキイ・インステイチユト 虫歯治療剤
US4556561A (en) * 1983-03-25 1985-12-03 American Dental Association Health Foundation Compositions and methods for topically fluoridating and/or mineralizing dental tissue
GB8316382D0 (en) * 1983-06-16 1983-07-20 Beecham Group Plc Toothpaste
US4726952A (en) * 1983-08-11 1988-02-23 Mission Pharmacal Slow-release sodium fluoride tablet, method of making, and method of treatment of osteoporosis
FR2556967B1 (fr) * 1983-10-13 1987-05-29 Goupil Jean Jacques Composition destinee a l'hygiene et a la sante du parodonte, des gencives et des dents
DE3433210C1 (de) * 1984-09-10 1986-06-05 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Mittel zur Fuellung von Knochen- und Zahndefekten,zum Knochenaufbau,fuer Knochenkontaktschichten und fuer Knochen- und Zahnwurzelersatz und Verwendung von Carbonatapatit fuer diesen Zweck
GB8510310D0 (en) * 1985-04-23 1985-05-30 Causton B E Dental treatment
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
US4861590A (en) * 1986-09-25 1989-08-29 Colgate-Palmolive Company Sustained release fluoride and calcium composition

Also Published As

Publication number Publication date
SE502686C2 (sv) 1995-12-11
NO873992D0 (no) 1987-09-24
US4859467A (en) 1989-08-22
IT8748403A0 (it) 1987-09-18
PH25636A (en) 1991-08-21
DK494887A (da) 1988-03-26
IL83652A (en) 1991-01-31
AU607154B2 (en) 1991-02-28
SE8703632D0 (sv) 1987-09-21
FR2604360A1 (fr) 1988-04-01
BE1000159A5 (fr) 1988-06-28
NO178527B (no) 1996-01-08
CH672071A5 (sv) 1989-10-31
GB8722454D0 (en) 1987-10-28
NZ221539A (en) 1990-08-28
BR8704889A (pt) 1988-05-17
NO178527C (no) 1996-04-17
IT1211791B (it) 1989-11-03
CA1294551C (en) 1992-01-21
GB2195245B (en) 1990-08-08
AR242497A1 (es) 1993-04-30
FR2604360B1 (fr) 1990-06-08
IL83652A0 (en) 1988-01-31
JPS6393710A (ja) 1988-04-25
ZA876281B (en) 1989-04-26
MX164095B (es) 1992-07-13
DK494887D0 (da) 1987-09-21
AU7749687A (en) 1988-03-31
GB2195245A (en) 1988-04-07
DE3727616A1 (de) 1988-03-31
NL8702297A (nl) 1988-04-18
NO873992L (no) 1988-03-28
JP2594576B2 (ja) 1997-03-26

Similar Documents

Publication Publication Date Title
ATE189400T1 (de) Knochenwachstumsfördernde zusammensetzung
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
NZ221805A (en) Oral, solid, controlled release pharmaceutical dosage form; preparatory processes
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
DE3374300D1 (en) Stabilized activated oxygen and medicaments containing this stabilized activated oxygen
ATE80996T1 (de) Arzneimittel mit verzoegerter freisetzung.
IL117356A (en) Controlled release matrix and pharmaceutical compositions for oral administration containing it
LU90192I2 (fr) Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc)
NZ222551A (en) A method of healing wounds and a method of regenerating bone; pharmaceutical composition of platelet-derived growth factor and insulin-like growth factor
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
SE8703632L (sv) For fordrojd frigivning anordnad fluoridkomposition
GB8817015D0 (en) Method of treatment
NO177336C (no) System for utbyttbart å bevare og beskytte en kontrollert-frigjörende intra-oral tablett
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
EP0313654A4 (en) MEDICINAL PRODUCTS FOR PROPHYLAXIS AND TREATMENT OF LIVER DISEASES.
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
NO912414D0 (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
FI933975A (fi) Tabletter som kontrollerat avgiver naproxen
OA09121A (fr) Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.
EP0383481A3 (en) Anesthetic oral compositions
IT1184287B (it) Composizione per la preparazione di un medicamento da usare per la cura della piorrea alveolare
JPS6438073A (en) Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition
GB2092442B (en) Pharmaceutical composition for treating diseases of the oral cavity containing glycyrrhetinic acid or a derivative thereof
SE8401968L (sv) Forfarande for framstellning av vel absorberbara orala lekemedelsdoseringsformer av medicinska 1,4-dihydropyridinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8703632-3

Format of ref document f/p: F